COVID-19 Vaccination for Children 5 through 11 Years Old

Information for Jurisdictions, Healthcare Providers, Pharmacists, Schools, and Community Partners

The federal government is committed to ensuring that children ages 5 through 11 years old have access to COVID-19 vaccines.  Scientists have conducted clinical trials with about 3,000 children, and the Food and Drug Administration (FDA) has determined that the Pfizer-BioNTech COVID-19 Vaccine has met the safety and efficacy standards for authorization in children ages 5 through 11 years old.  The safety of COVID-19 vaccines continues to be monitored.

This page shares up-to-date information and resources on how to help get children ages 5 through 11 years old vaccinated.

COVID-19 Vaccination Recommendations for Pediatric Populations

Children 5 years and older can get the Pfizer-BioNTech COVID-19 Vaccine. Children 5 through 11 years old will receive a separate vaccine formulation denoted with an orange cap of the Pfizer-BioNTech COVID-19 Vaccine, and will receive the vaccine with a smaller needle. An overview of the description of the differences in the adult/adolescent formulation and pediatric formulationpdf icon is available.

Children between the ages of 2 and 4 years old, other unvaccinated children 5 years or older and adults should continue to wear a mask in public spaces and around people they don’t live with.

Planning and Promoting COVID-19 Vaccination in Your Community
illustration of checklists

Pediatric COVID-19 Operational Planning Guidepdf icon

This guide outlines key aspects of a COVID-19 vaccination program for children 5 through 11 years old and was designed to inform jurisdictional planning under the assumption of FDA authorization and CDC recommendations of at least one COVID-19 vaccine product for children of this age. An overview of the description of the differences in the adult/adolescent formulation and pediatric formulationpdf icon is available.

Clinical Training and Education
Page last reviewed: November 18, 2021